Ørsted A/S (OTCMKTS:DNNGY – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totaling 117,425 shares, a decline of 35.2% from the September 30th total of 181,104 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 262,237 shares, the days-to-cover ratio is presently 0.4 days.
Ørsted A/S Stock Performance
DNNGY opened at $6.55 on Monday. The business has a 50 day moving average of $6.76 and a 200-day moving average of $7.53. Ørsted A/S has a 52 week low of $5.75 and a 52 week high of $9.04.
Analyst Ratings Changes
DNNGY has been the subject of several research analyst reports. The Goldman Sachs Group cut shares of Ørsted A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 13th. Royal Bank Of Canada upgraded shares of Ørsted A/S to a “moderate buy” rating in a research report on Tuesday, September 1st. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.
Get Our Latest Report on DNNGY
Ørsted A/S Company Profile
Ørsted A/S is a Danish renewable energy company focused primarily on developing, constructing, owning and operating offshore wind farms. Its activities also include onshore wind, solar power, energy storage and other renewable energy projects, as well as related operations and maintenance services.
The company was established in 1972 as Dansk Naturgas, later known as DONG Energy, and initially operated across oil, natural gas and conventional energy markets. Following a strategic transition away from fossil fuels, the company adopted the name Ørsted in 2017 to reflect its focus on renewable energy.
Read More
- Five stocks we like better than Ørsted A/S
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Ørsted A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ørsted A/S and related companies with MarketBeat.com's FREE daily email newsletter.
